evaluate the pharmaceuticals company byetta on semaglutide for weight loss 🚨 As GLP-1 Use Explodes, Long-Term Safety Questions Are Growing Too From pancreatitis and gallbladder disease to rare liver safety concerns, experts say rapid expansion of GLP-1 drugs like and How Effective Is Semaglutide for

The Bottom Line GLP-1 medications can be highly effective tools for managing obesity and diabetes, but cost remains a significant barrier for many people

From a commercial standpoint, thats a nightmare

The spending increase is driven primarily by higher outpatient costs, an increase of $438 in the first year, likely reflecting monitoring visits for dose titration and managing side effects

The earliest realistic approval timeline is late 2027 to 2028, assuming positive Phase 3 trial results and a standard FDA review process

EBioMedicine (2016) 7:11220

[1] [4] Patients should contact their GP or NHS 111 urgently if they experience severe, persistent abdominal pain (which may indicate pancreatitis or gallbladder disease), persistent vomiting, jaundice, or signs of dehydration